PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 16493010-2 2006 Annexin 2 (A2) is a profibrinolytic endothelial cell surface receptor that binds plasminogen, its tissue activator (tPA), and beta(2)-glycoprotein I (beta2GPI), the main antigen for antiphospholipid antibodies. Tetradecanoylphorbol Acetate 116-119 annexin A2 Homo sapiens 0-9 19377918-4 2009 Though both tPA and uPA are expressed in tumor cells, uPA with its receptor (uPAR) is mostly involved in cellular functions, while tPA with its receptor Annexin II on endothelial surface, regulates intravascular fibrin deposition. Tetradecanoylphorbol Acetate 131-134 annexin A2 Homo sapiens 153-163 18220793-4 2007 Annexin II is one of the well studied receptors for plasminogen and tPA, which binds to plasminogen and converts it to plasmin. Tetradecanoylphorbol Acetate 68-71 annexin A2 Homo sapiens 0-10 16493010-2 2006 Annexin 2 (A2) is a profibrinolytic endothelial cell surface receptor that binds plasminogen, its tissue activator (tPA), and beta(2)-glycoprotein I (beta2GPI), the main antigen for antiphospholipid antibodies. Tetradecanoylphorbol Acetate 116-119 annexin A2 Homo sapiens 11-13 16493010-6 2006 Anti-A2 IgG enhanced the expression of tissue factor on endothelial cells (6.4-fold +/- 0.13-fold SE), blocked A2-supported plasmin generation in a tPA-dependent generation assay (19%-71%) independently of beta2GPI, and inhibited cell surface plasmin generation on human umbilical vein endothelial cells (HUVECs) by 34% to 83%. Tetradecanoylphorbol Acetate 148-151 annexin A2 Homo sapiens 5-7 16493010-6 2006 Anti-A2 IgG enhanced the expression of tissue factor on endothelial cells (6.4-fold +/- 0.13-fold SE), blocked A2-supported plasmin generation in a tPA-dependent generation assay (19%-71%) independently of beta2GPI, and inhibited cell surface plasmin generation on human umbilical vein endothelial cells (HUVECs) by 34% to 83%. Tetradecanoylphorbol Acetate 148-151 annexin A2 Homo sapiens 111-113 12468550-0 2003 New insights into the tPA-annexin A2 interaction. Tetradecanoylphorbol Acetate 22-25 annexin A2 Homo sapiens 26-36 12627665-10 2003 Another example was seen recently in the antiphospholipid syndrome, where antibodies against Annexin II, a receptor for tPA, were found to be higher than in healthy controls. Tetradecanoylphorbol Acetate 120-123 annexin A2 Homo sapiens 93-103 12468550-4 2003 The annexin A2 motif that mediates tissue plasminogen activator interaction has been assigned to the hexapeptide LCKLSL in the amino-terminal domain of the protein, and it has been proposed that Cys(8) of this sequence is essential for tPA binding. Tetradecanoylphorbol Acetate 236-239 annexin A2 Homo sapiens 4-14 12468550-5 2003 In an attempt to identify other amino acids critical for tPA-annexin A2 interaction, we have analyzed a set of peptides containing several modifications of the original hexapeptide, including glycine scans, alanine scans, d-amino acid scans, conservative mutations, cysteine blocking, and enantiomer and retroenantiomer sequences. Tetradecanoylphorbol Acetate 57-60 annexin A2 Homo sapiens 61-71 12468550-6 2003 Using a non-radioactive competitive binding assay, we have found that all cysteine-containing peptides, independently of their sequence, compete the interaction between tPA and annexin A2. Tetradecanoylphorbol Acetate 169-172 annexin A2 Homo sapiens 177-187 12468550-9 2003 These data call for a revision of the role of the LCKLSL sequence as the sole annexin A2 structural region required to bind tPA and indicate that further studies are necessary to better define the annexin A2-tPA interaction. Tetradecanoylphorbol Acetate 208-211 annexin A2 Homo sapiens 197-207 7980409-6 1994 After stimulation with phorbol 12-myristate 13-acetate and phytohaemagglutinin for 10 min, p105-NF-kappa B and p50-NF-kappa B, but not p36-I kappa B, were highly phosphorylated. Tetradecanoylphorbol Acetate 23-54 annexin A2 Homo sapiens 135-138 23702712-11 2013 ANX A2 depletion significantly inhibited TNF-alpha shedding by interleukin-1beta and TPA. Tetradecanoylphorbol Acetate 85-88 annexin A2 Homo sapiens 0-6 23702712-14 2013 CONCLUSIONS: ANX A2 was closely associated with ADAM17 and played an important role in TNF-alpha shedding by TPA. Tetradecanoylphorbol Acetate 109-112 annexin A2 Homo sapiens 13-19 33140258-5 2021 Potential pathologic factors that are related to the suboptimal tPA recanalization in diabetic stroke include higher plasma plasminogen activator inhibitor (PAI)-1 level, diabetic atherogenic vascular damage, glycation of the tPA receptor annexin A2, and alterations in fibrin clot density. Tetradecanoylphorbol Acetate 64-67 annexin A2 Homo sapiens 239-249